ANALYSIS: Why do shareholders appoint a patsy to their boards just before their companies fail?
ANALYSIS: Bloody-minded officials put kibosh yet again on mandatory new-build warranties.
ANALYSIS: The Bioplant group and its offshore partners mum on financing of Manawatū waste-to-energy project.
ANALYSIS: With eight months down, 2022 not looking like a good year for a float.
ANALYSIS: Is Zuru a corporate bullyboy, or is defamation action against former employees a sign of a maturing internet?
ANALYSIS: Promoting high-risk offers on Facebook and Instagram seems here to stay, so is more disclosure required?
ANALYSIS: Why Kiwi companies are flocking to set up US hubs in Denver.
Under duress the supermarket duopoly is transforming – but aims to retain its invisible hand.
ANALYSIS: Rocket Lab's share price has crashed since listing, but there are reasons for optimism.
ANALYSIS: ‘Once-in-a-generation’ review opened for consultation last week.